ES2279970T3 - Polimorfo b de un ester dodecahidrociclopenta(a)fenantrenilico de acido tiofenocarboxilico conocido. - Google Patents

Polimorfo b de un ester dodecahidrociclopenta(a)fenantrenilico de acido tiofenocarboxilico conocido. Download PDF

Info

Publication number
ES2279970T3
ES2279970T3 ES03766325T ES03766325T ES2279970T3 ES 2279970 T3 ES2279970 T3 ES 2279970T3 ES 03766325 T ES03766325 T ES 03766325T ES 03766325 T ES03766325 T ES 03766325T ES 2279970 T3 ES2279970 T3 ES 2279970T3
Authority
ES
Spain
Prior art keywords
compound
formula
crystalline form
inflammatory
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES03766325T
Other languages
English (en)
Spanish (es)
Inventor
Guido Jordine
Michael Mutz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Application granted granted Critical
Publication of ES2279970T3 publication Critical patent/ES2279970T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J33/00Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J33/00Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J33/002Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
ES03766325T 2002-07-29 2003-07-28 Polimorfo b de un ester dodecahidrociclopenta(a)fenantrenilico de acido tiofenocarboxilico conocido. Expired - Lifetime ES2279970T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0217504 2002-07-29
GBGB0217504.0A GB0217504D0 (en) 2002-07-29 2002-07-29 Organic compounds

Publications (1)

Publication Number Publication Date
ES2279970T3 true ES2279970T3 (es) 2007-09-01

Family

ID=9941275

Family Applications (1)

Application Number Title Priority Date Filing Date
ES03766325T Expired - Lifetime ES2279970T3 (es) 2002-07-29 2003-07-28 Polimorfo b de un ester dodecahidrociclopenta(a)fenantrenilico de acido tiofenocarboxilico conocido.

Country Status (30)

Country Link
US (1) US7683048B2 (fr)
EP (2) EP1676854A1 (fr)
JP (1) JP2006501207A (fr)
KR (1) KR100688371B1 (fr)
CN (1) CN1305892C (fr)
AR (1) AR040692A1 (fr)
AT (1) ATE349459T1 (fr)
AU (1) AU2003251651B2 (fr)
BR (1) BR0313044A (fr)
CA (1) CA2493330C (fr)
CY (1) CY1106406T1 (fr)
DE (1) DE60310747T2 (fr)
DK (1) DK1554303T3 (fr)
EC (1) ECSP055579A (fr)
ES (1) ES2279970T3 (fr)
GB (1) GB0217504D0 (fr)
HK (1) HK1080484B (fr)
IL (2) IL166287A0 (fr)
MX (1) MXPA05001173A (fr)
MY (1) MY136407A (fr)
NO (1) NO20050806L (fr)
NZ (2) NZ537868A (fr)
PE (1) PE20040722A1 (fr)
PL (1) PL209409B1 (fr)
PT (1) PT1554303E (fr)
RU (2) RU2348646C1 (fr)
SI (1) SI1554303T1 (fr)
TW (1) TWI309164B (fr)
WO (1) WO2004013156A1 (fr)
ZA (1) ZA200500370B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
GB0523654D0 (en) * 2005-11-21 2005-12-28 Novartis Ag Organic compounds
GB0523656D0 (en) * 2005-11-21 2005-12-28 Novartis Ag Organic compounds
GB0603783D0 (en) * 2006-02-24 2006-04-05 Novartis Ag Organic compounds
JP2011513203A (ja) * 2008-03-14 2011-04-28 大塚製薬株式会社 Mmp−2及び/又はmmp−9阻害剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU550939A1 (ru) * 1975-05-19 1994-07-15 Институт химии древесины АН ЛатвССР 1,2,3,4,4а,4в,5,6,10,10а -декагидро -6- хлорацетоксиметил -1,4а-диметил -7- (1-метилэтил) -1- фенантренкарбоновая кислота или ее соли
JPH08291073A (ja) * 1995-04-22 1996-11-05 Kissei Pharmaceut Co Ltd 医薬品組成物及びその製造方法
GB0015876D0 (en) * 2000-06-28 2000-08-23 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
NO20050806L (no) 2005-02-15
RU2348646C1 (ru) 2009-03-10
GB0217504D0 (en) 2002-09-04
IL166287A0 (en) 2006-01-15
EP1554303B1 (fr) 2006-12-27
BR0313044A (pt) 2005-06-14
NZ549713A (en) 2008-04-30
US20060166954A1 (en) 2006-07-27
RU2005105688A (ru) 2005-10-10
EP1554303A1 (fr) 2005-07-20
ATE349459T1 (de) 2007-01-15
TWI309164B (en) 2009-05-01
CY1106406T1 (el) 2011-10-12
PT1554303E (pt) 2007-03-30
PL373140A1 (en) 2005-08-22
AU2003251651A1 (en) 2004-02-23
MY136407A (en) 2008-09-30
IL184848A0 (en) 2007-12-03
CN1671731A (zh) 2005-09-21
SI1554303T1 (sl) 2007-06-30
CA2493330A1 (fr) 2004-02-12
AU2003251651B2 (en) 2007-07-12
CA2493330C (fr) 2011-08-23
RU2007143025A (ru) 2009-01-20
DE60310747D1 (en) 2007-02-08
AR040692A1 (es) 2005-04-13
NZ537868A (en) 2006-11-30
CN1305892C (zh) 2007-03-21
DK1554303T3 (da) 2007-04-30
KR100688371B1 (ko) 2007-03-02
ZA200500370B (en) 2006-07-26
ECSP055579A (es) 2005-04-18
MXPA05001173A (es) 2005-05-16
PE20040722A1 (es) 2004-11-29
HK1080484A1 (en) 2006-04-28
HK1080484B (zh) 2007-08-03
JP2006501207A (ja) 2006-01-12
US7683048B2 (en) 2010-03-23
RU2330043C2 (ru) 2008-07-27
PL209409B1 (pl) 2011-08-31
DE60310747T2 (de) 2007-10-11
WO2004013156A1 (fr) 2004-02-12
EP1676854A1 (fr) 2006-07-05
TW200401633A (en) 2004-02-01
KR20050033632A (ko) 2005-04-12

Similar Documents

Publication Publication Date Title
US6800643B2 (en) Mixtures for organic compounds for the treatment of airway diseases
ES2320994T3 (es) Derivados de la quinolina-2-ona para el tratamiento de enfermedades de las vias respiratorias.
US20080279948A1 (en) Treatment of Asthma and Copd Using Triple-Combination Therapy
AU2002217082A1 (en) Mixtures or organic compounds for the treatment of airway diseases
US20080286363A1 (en) Pharmaceutical Compositions for the Treatment of Inflammatory and Obstructive Airways Diseases
ES2396987T3 (es) Derivados de quinolina y sus composiciones farmacéuticas
ES2279970T3 (es) Polimorfo b de un ester dodecahidrociclopenta(a)fenantrenilico de acido tiofenocarboxilico conocido.
TW200817333A (en) Organic compounds
EP1900737A1 (fr) Polymorphe de (R)-3-(2-hydroxy-2,2-diphenyl-acetoxy)-1-(isoxazol-3-ylcarbamoyl-methyl)-1-azonia-bicyclo-[2.2.2]octane bromide
AU2007202962A1 (en) Polymorphis of a known thiophenecarboxylic acid dodecahydrocyclopenta (A) phenanthrenyl ester